Details of the Drug

General Information of Drug (ID: DMTUK2E)

• Drug Name: AVT001

Indication

Disease Entry	ICD 11	Status	REF
Type-1 diabetes	5A10	Phase 1/2	[1]

• Drug Type: Cell therapy
• Cross-matching ID: TTD ID: DD52FT

References

• [1] ClinicalTrials.gov (NCT03895996) A Phase 1 / 2 Double-Blind, Randomized, Placebo Controlled Study of Safety, Tolerability and Potential Efficacy of AVOTRES Cell-Based Therapy (AVT001) in Patients With Type 1 Diabetes. U.S.National Institutes of Health.